Abstract
Hemoglobinopathies, such as β-thalassemia and sickle cell disease (SCD), are among the most common congenital diseases in the world, with high mortality and morbidity rates. The most straightforward approach to correct the main culprit in hemoglobinopathies - the imbalance between the amounts of alpha-like globins/betalike globins- will need to target directly the gene structure or their regulatory elements in order to obtain a sustained therapeutic effect.
Finding effective methods to deliver the genetic “blueprints” of the correct and functional protein or, even better, the “DNA repairing kit” able to do the job in situ, remains a major challenge, despite the fact that gene therapy is already used in different diseases. Members of several viral families were employed as “Trojan horses” using the virus ability to deliver a modified genetic material inside the cell and to manipulate the host replication machinery to produce the encoded proteins. Recently, non-viral vectors are gaining advantages for genome correction, especially after the exponential development of the genome editing approaches that can provide precise in situ modifications. This review summarizes the recent advances in the viral and non-viral delivery strategies and emphasizes the therapeutic potential of different approaches designed to correct the genetic defects responsible for the most common hemoglobinopathies.Keywords: Genetic therapy, nucleic acids delivery strategies, hemoglobinopathies, DNA repairing, DNA editing, viral and non-viral vectors, nanoparticles.
Current Organic Chemistry
Title:Delivering the "Blueprints" or "DNA Repairing Kits" Instead of Drugs in the Treatment of Congenital Hemoglobinopathies
Volume: 21 Issue: 1
Author(s): Diana Chiru, Cristina Mambet, Lilia Matei, Coralia Bleotu, Simona Ruta and Carmen C. Diaconu
Affiliation:
Keywords: Genetic therapy, nucleic acids delivery strategies, hemoglobinopathies, DNA repairing, DNA editing, viral and non-viral vectors, nanoparticles.
Abstract: Hemoglobinopathies, such as β-thalassemia and sickle cell disease (SCD), are among the most common congenital diseases in the world, with high mortality and morbidity rates. The most straightforward approach to correct the main culprit in hemoglobinopathies - the imbalance between the amounts of alpha-like globins/betalike globins- will need to target directly the gene structure or their regulatory elements in order to obtain a sustained therapeutic effect.
Finding effective methods to deliver the genetic “blueprints” of the correct and functional protein or, even better, the “DNA repairing kit” able to do the job in situ, remains a major challenge, despite the fact that gene therapy is already used in different diseases. Members of several viral families were employed as “Trojan horses” using the virus ability to deliver a modified genetic material inside the cell and to manipulate the host replication machinery to produce the encoded proteins. Recently, non-viral vectors are gaining advantages for genome correction, especially after the exponential development of the genome editing approaches that can provide precise in situ modifications. This review summarizes the recent advances in the viral and non-viral delivery strategies and emphasizes the therapeutic potential of different approaches designed to correct the genetic defects responsible for the most common hemoglobinopathies.Export Options
About this article
Cite this article as:
Chiru Diana, Mambet Cristina, Matei Lilia, Bleotu Coralia, Ruta Simona and Diaconu C. Carmen, Delivering the "Blueprints" or "DNA Repairing Kits" Instead of Drugs in the Treatment of Congenital Hemoglobinopathies, Current Organic Chemistry 2017; 21 (1) . https://dx.doi.org/10.2174/1385272820666160511122404
DOI https://dx.doi.org/10.2174/1385272820666160511122404 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Reconstructing the Hsp90/Tau Machine
Current Enzyme Inhibition Drug Delivery from Therapeutic Self-Assembled Monolayers (T-SAMs) on 316L Stainless Steel
Current Topics in Medicinal Chemistry Dysregulation of lncRNA and circRNA Expression in Mouse Testes after Exposure to Triptolide
Current Drug Metabolism Neurokinin-1 (NK<sub>1</sub>) receptor antagonists as possible therapeutics for psychostimulant use disorders
CNS & Neurological Disorders - Drug Targets Patent Selections
Recent Patents on Biomarkers Genes Involved in Hereditary Hearing Impairment
Current Genomics CD36 as a Multiple-Ligand Signaling Receptor in Atherothrombosis
Cardiovascular & Hematological Agents in Medicinal Chemistry A New Method for a Quantitative Determination of Piroxicam in Pharmaceutical Formulations Using FT-IR Spectrometry
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Risk Factors for Cardiovascular Disease in Psoriasis: Relation to Inflammation Assessed by the Severity and Duration of Illness
Inflammation & Allergy - Drug Targets (Discontinued) Human Umbilical Cord Mesenchymal Stem Cells Therapy for Insulin Resistance: A Novel Strategy in Clinical Implication
Current Stem Cell Research & Therapy IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression
Current Drug Targets Evolutioninthe Pharmacogenetics and Pharmacogenomics of Inflammatory Bowel Disease - Order Slowly Rises from the Chaos
Current Pharmacogenomics Foreword
Current Nutrition & Food Science Potential Deployment of Angiotensin I Converting Enzyme Inhibitors and of Angiotensin II Type 1 and Type 2 Receptor Blockers in Cancer Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry New Insights into the Immune Response to Pneumococci
Current Respiratory Medicine Reviews Vitamin D: Status, Supplementation and Immunomodulation
Current Nutrition & Food Science Editorial [Hot Topic: Protein Kinase Inhibitors for the Treatment of Inflammatory Disease (Guest Editor: Mark R. Player)]
Current Topics in Medicinal Chemistry Progress Towards Liver and Lung-Directed Gene Therapy with Helper- Dependent Adenoviral Vectors
Current Gene Therapy Ceramide and Sphingosine-1-Phosphate in Cell Death Pathways : Relevance to the Pathogenesis of Alzheimer's Disease
Current Alzheimer Research Combination of Statin Plus Renin Angiotensin System Inhibition for the Prevention or the Treatment of Atherosclerotic Cardiovascular Disease
Current Pharmaceutical Design